na 931 vs retatrutide Oral quadruple receptor agonist confers weight loss with minimal GI adverse events Move over #retatrutide the #QuintupleAgonist
Description
GLP-1s also reduce your appetite, so you end up eating less
Most patients experience a reduction in appetite, which helps them make healthier food choices and may contribute to gradual weight loss
Evaluation of Out-of-Pocket costs and treatment intensification with an SGLT2 inhibitor or GLP-1 RA in patients with type 2 diabetes and cardiovascular disease
In patients with diabetes, GLP-1 RAs have been linked to an increased risk of age-related macular degeneration, although the overall risk is still low[38]
Lean, M
